Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Star Combo Pharma Ltd. ( (AU:S66) ) has provided an announcement.
Star Combo Pharma Ltd. has announced its 2025 Annual General Meeting (AGM) scheduled for November 25th, 2025, at its Smithfield, NSW headquarters. The meeting will address key business items including the consideration of financial statements, the adoption of the remuneration report, and the re-election of Ms. Wei Han as a director. Shareholders can participate in person, via proxy, or online, highlighting the company’s efforts to ensure inclusive shareholder engagement.
The most recent analyst rating on (AU:S66) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Star Combo Pharma Ltd. stock, see the AU:S66 Stock Forecast page.
More about Star Combo Pharma Ltd.
Star Combo Pharma Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of health supplements and skincare products. The company is known for its commitment to quality and innovation, serving both domestic and international markets.
Average Trading Volume: 28,218
Technical Sentiment Signal: Buy
Current Market Cap: A$27M
For a thorough assessment of S66 stock, go to TipRanks’ Stock Analysis page.